AzTrials
AzTrials

Fluorosis, DentalNCT07707349

The Effectiveness of Antivet Versus Opalustre® for the Management of Enamel Fluorosis/Discolored Enamel and Its Impact on Aesthetic Outcomes.

A study testing Antivet and Opalusture in people with Fluorosis, Dental and Enamel Discoloration, run by October University for Modern Sciences and Arts at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dental fluorosis is a developmental enamel defect characterized by discoloration and altered enamel appearance, which may negatively affect dental esthetics and patient satisfaction. Read more about this study

Who is it for?
Ages 20 to 35 years
Conditions the study is for
Fluorosis, Dental, Enamel Discoloration
What is being tested?
Antivet and Opalusture
Could I receive a placebo?
No, everyone receives an active treatment
How many people
59 participants
Where
1 siteEgypt
Study dates
18 May 2026to 7 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients aged from 20-35 years old.
  • Patients free from any systematic diseases.
  • Patients agreed to the informed consent and are compliant to the follow-up periods.
  • Teenagers and young adult patients refrained from tobacco products throughout the current study period.
  • Patients with hypominerlized maxillary and mandibular ante- rior teeth (incisors and canines) were included.
  • Teeth with Degree 1 (mild) according to the Wetzel and Reckel scale.

Who cannot join

  • Patients with special health care needs or any systemic disease that may delay normal healing.
  • Patients having bad oral hygiene.
  • Patients who could not be committed to the follow-up period.
  • Patients suffering from untreated, periodontal diseases
  • Participants with caries lesions or defective restorations in the anterior teeth.
  • Sensitive and fractured teeth.
Show all 9Show fewer
  • Participants who had a history of dental bleaching.
  • Patients participating in other dental studies.
  • Patients suffering from hypoplasia, amelogenesis imperfecta, dentinogenesis imperfecta, tetracycline stains, fluorosis, or badly broken and missing teeth due to MIH.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • October University for Modern Sciences and Arts

    Giza, Sixth of October, 12566

Other trials in Egypt

About this study

Official title: The Effectiveness of Antivet Versus Opalustre® for the Management of Enamel Fluorosis/Discolored Enamel and Its Impact on Aesthetic Outcomes. A Randomized Controlled Trial

Dental fluorosis is a developmental enamel defect characterized by discoloration and altered enamel appearance, which may negatively affect dental esthetics and patient satisfaction. Conservative treatment approaches, including enamel microabrasion and minimally invasive chemical treatments, have been proposed to improve the appearance of affected teeth while preserving tooth structure. However, evidence comparing the effectiveness of these treatment modalities remains limited.

This randomized controlled clinical trial aims to compare the effectiveness of Antivet treatment and Opalustre enamel microabrasion in improving the esthetic appearance of mild enamel fluorosis/discolored enamel affecting anterior teeth. Eligible participants with mild enamel fluorosis will be randomly allocated to receive either Antivet treatment or Opalustre enamel microabrasion in a 1:1 ratio. Tooth color will be objectively assessed before and after treatment using a spectrophotometer based on the CIELAB color system (L*, a*, and b* coordinates), and the overall color difference (ΔE) will be calculated. The primary outcome is the change in tooth color following treatment, while secondary outcomes include changes in individual CIELAB color coordinates. The findings of this study are expected to provide evidence regarding the comparative effectiveness of these minimally invasive treatment modalities for the esthetic management of mild enamel fluorosis.

Read the detailed description

Dental fluorosis is a developmental enamel defect resulting from excessive fluoride intake during enamel formation. It is characterized by varying degrees of enamel opacity, discoloration, and surface irregularities that may compromise dental esthetics and negatively affect patients' quality of life. Conservative treatment approaches are preferred for managing mild fluorosis because they preserve sound tooth structure while improving esthetic appearance. Among these approaches, enamel microabrasion has been widely used to remove superficial enamel discolorations through the combined action of hydrochloric acid and abrasive particles. More recently, minimally invasive chemical treatment systems, such as Antivet, have been introduced as alternative treatment options for improving enamel discoloration while minimizing the removal of sound enamel.

Although both treatment modalities have demonstrated favorable clinical outcomes, evidence directly comparing their effectiveness in improving tooth color remains limited. Therefore, this randomized controlled clinical trial was designed to compare the esthetic outcomes of Antivet treatment and Opalustre enamel microabrasion in the management of mild enamel fluorosis affecting anterior teeth.

Eligible participants presenting with mild enamel fluorosis involving permanent maxillary or mandibular anterior teeth were randomly assigned in a 1:1 allocation ratio to receive either Antivet treatment or Opalustre enamel microabrasion. All treatment procedures were performed according to the manufacturers' recommendations under rubber dam isolation to ensure adequate moisture control and protection of the surrounding soft tissues.

The primary outcome measure was the change in tooth color following treatment, objectively assessed using a spectrophotometer based on the Commission Internationale de l'Éclairage (CIELAB) color system. Color coordinates (L*, a*, and b*) were recorded before and after treatment, and the overall color difference (ΔE) was calculated to quantify treatment-induced color improvement. Secondary outcome measures included changes in individual CIELAB color coordinates, including lightness (L*), red-green chromaticity (a*), and yellow-blue chromaticity (b*).

Statistical analysis included paired-samples and independent-samples t-tests to evaluate within-group and between-group differences. Because baseline differences in chromaticity were identified, analysis of covariance (ANCOVA) was performed using baseline color values as covariates to provide adjusted comparisons between treatment groups. Statistical significance was established at a two-sided α level of 0.05.

The findings of this study are expected to provide high-quality clinical evidence regarding the comparative effectiveness of two minimally invasive treatment modalities for improving the esthetic appearance of fluorosis-affected anterior teeth. The results may assist clinicians in selecting conservative treatment approaches that optimize esthetic outcomes while preserving enamel structure.

Being tested
Antivet, Opalusture
Keywords
Enamel Fluorosis, Enamel discoloration, Antivet, Opalusture, Micro abrasion, Spectrophotometer
Medical subject headings
Fluorosis, Dental

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AntivetOther

    Microabrasion

  • OpalustureOther

    Enamel Micro abrasion

Study groups in NCT07707349
Study groupRoleWhat they receive
AntivetExperimentalNot described
Receives: Other: Antivet
Opalusture microabrasionActive comparatorNot described
Receives: Other: Opalusture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The mean change in color

    The primary outcome measure was the change in tooth color following treatment, objectively assessed using a spectrophotometer based on the Commission Internationale de l'Éclairage (CIELAB) color system. Color coordinates (L*, a*, and b*) were recorded at the base line and then after the intervention was applied in the same visit and the overall color difference (ΔE) was calculated to quantify treatment-induced color improvement.

    Measured: Baseline (before treatment) and immediately after completion of the intervention (same visit Day 1).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2026
  2. Study start18 May 2026
  3. Primary completion15 Jun 2026
  4. Study completion7 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants meeting the eligibility criteria were randomly assigned in a 1:1 allocation ratio to one of two parallel treatment groups. The intervention group received Antivet treatment, while the control group underwent enamel microabrasion using Opalustre. Each participant received only one of the two interventions, and treatment allocation remained unchanged throughout the study. The effectiveness of both treatment modalities was evaluated by comparing changes in tooth color before and after treatment using objective spectrophotometric measurements based on the CIELAB color system.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
59 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07707349
Sponsor's protocol ID
REC-D12295-6
Status last verified
May 2026
First submitted
9 Jul 2026
Last updated
16 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • 10.21608/edj.2023.217606.2603

  • Diab DFS, Elhaddad EEH. Comparative effect of Antivet(R), Oplasture(R), and a prototype paste on color change and microhardness of simulated stained enamel: an in vitro study. BDJ Open. 2025 Dec 30;11(1):100. doi: 10.1038/s41405-025-00393-x.

    PubMed 41469534

Questions about this trial

What is this clinical trial studying?

A study testing Antivet and Opalusture in people with Fluorosis, Dental and Enamel Discoloration, run by October University for Modern Sciences and Arts at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The mean change in color (time frame: Baseline (before treatment) and immediately after completion of the intervention (same visit Day 1).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07707349, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in